These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7662682)

  • 21. DMPA for contraception discussed by international forum of experts.
    Netw Int Fertil Res Program; 1979 Oct; ():2-3. PubMed ID: 12261372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FDA gives final approval to Depo amid concerns over safety, cost and coercion.
    Wash Memo Alan Guttmacher Inst; 1992 Nov; (17):2-3. PubMed ID: 12344620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. State also pays for Depo-Provera.
    Hanson MS
    Minn Med; 1991 Jun; 74(6):7-8. PubMed ID: 1830920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Depo-Provera: costs eat up clinic contraceptive budgets.
    Contracept Technol Update; 1999 Jan; 20(1):1-3. PubMed ID: 12349019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Depo-Provera and Norplant implants prove no competition for no. 1 choice, OCs. The 1994 pill survey.
    American Health Consultants
    Contracept Technol Update; 1994 Dec; 15(12):157-61. PubMed ID: 12288903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current concepts regarding use of DMPA.
    Kaunitz AM
    J Reprod Med; 2002 Sep; 47(9 Suppl):785-9. PubMed ID: 12380407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Injectable contraception: the USA perspective.
    Kaunitz AM
    IPPF Med Bull; 1992 Dec; 26(6):1-3. PubMed ID: 12346920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of levonorgestrel implants with depo-medroxyprogesterone acetate injections for contraception.
    London RS
    J SOGC; 1993 Oct; 15(8):925-8, 32. PubMed ID: 12318530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Injectable medroxyprogesterone.
    Rosenfield AG
    Drug Ther (NY); 1975 Jul; 5():139. PubMed ID: 12229496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug regulation in the United States and the United Kingdom: the Depo-Provera story.
    Richard BW; Lasagna L
    Ann Intern Med; 1987 Jun; 106(6):886-91. PubMed ID: 2953290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Longitudinal study of depot medroxyprogesterone acetate (Depo-Provera) effects on bone health in adolescents: study design, population characteristics and baseline bone mineral density.
    Johnson CC; Burkman RT; Gold MA; Brown RT; Harel Z; Bruner A; Stager M; Bachrach LK; Hertweck SP; Nelson AL; Nelson DA; Coupey SM; McLeod A; Bone HG
    Contraception; 2008 Apr; 77(4):239-48. PubMed ID: 18342646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of injectable progestin (medroxyprogesterone acetate) in adolescent health care.
    Isart F; Weber FT; Merrick CL; Rowe S
    Contraception; 1992 Jul; 46(1):41-8. PubMed ID: 1424622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In favor of continued use of depot medroxyprogesterone acetate (DMPA, Depo-Provera) in adolescents.
    Cromer B
    J Pediatr Adolesc Gynecol; 2005 Jun; 18(3):183-7. PubMed ID: 15970253
    [No Abstract]   [Full Text] [Related]  

  • 34. ARHP launches Depo-Provera education program.
    Kaunitz A
    Health Sex; 1993; 3(3):18, 24. PubMed ID: 12286568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Depot-medroxyprogesterone acetate: an update.
    Bakry S; Merhi ZO; Scalise TJ; Mahmoud MS; Fadiel A; Naftolin F
    Arch Gynecol Obstet; 2008 Jul; 278(1):1-12. PubMed ID: 18470526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Should depot medroxyprogesterone acetate be considered for additional uses?
    Kinch RA
    Can Med Assoc J; 1982 Nov; 127(10):947-8. PubMed ID: 7139435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Depo-Provera: IPPF states the facts.
    IPPF News; 1978; 3(5):1. PubMed ID: 12260347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Depot medroxyprogesterone acetate (DMPA, Depo-Provera) in adolescents: what is next after the FDA black box warning.
    Omar H; Kives S
    J Pediatr Adolesc Gynecol; 2005 Jun; 18(3):183. PubMed ID: 15970252
    [No Abstract]   [Full Text] [Related]  

  • 39. Satisfaction with and intention to continue Depo-Provera versus the Mirena IUD among post-partum adolescents through 12 months of follow-up.
    Howard DL; Wayman R; Strickland JL
    J Pediatr Adolesc Gynecol; 2013 Dec; 26(6):358-65. PubMed ID: 24238267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-acting contraceptive options.
    Kaunitz AM
    Int J Fertil Menopausal Stud; 1996; 41(2):69-76. PubMed ID: 8829701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.